December 6, 2007 -- The ChinaBio® Investor Forum 2007, held December 4-5, 2007 in Shanghai, gave the “Most Promising” award to two early stage China biotech companies. PanAsia Bio of Shanghai won the prize in the Drug Company category, and Chiral Quest of Suzhou was the recipient in the Services group. PanAsia Bio uses pegylation technology to develop PEG-based drugs. Chiral Quest, Inc. is a contract manufacturer of chiral drug candidates. The two companies were chosen from a list of sixteen companies that made presentations to the forum. More details...
